As previously reported, NDFIP1 is regarded as a tumor suppressor in uveal melanoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, and breast cancer (Peng et al., 2017; Zhang et al., 2019; Ben et al., 2020; Tian et al., 2020). This evidence concerns the gene NDFIP1 and pancreatic ductal adenocarcinoma.